Blood levels of o,p′-DDD following administration in various vehicles after a single dose and during long-term treatment
- 1 December 1981
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 7 (1) , 51-54
- https://doi.org/10.1007/bf00258213
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Treatment of Cushing's Disease by o,p′DDDNew England Journal of Medicine, 1979
- o,p′-DDD (mitotane) therapy of adrenal cortical carcinoma. Observations on drug dosage, toxicity, and steroid replacementCancer, 1978
- Estimation of o,p'-DDD in plasma by gas-liquid chromatographyClinica Chimica Acta; International Journal of Clinical Chemistry, 1977
- Aromatic Hydroxylation and Alkyl Oxidation in Metabolism of Mitotane (o,p'-DDD) in HumansJournal of Pharmaceutical Sciences, 1974
- Mitotane Use in Inoperable Adrenal Cortical CarcinomaJAMA, 1973
- Treatment of Cushing's DiseaseNew England Journal of Medicine, 1969
- Adrenal cortical carcinomaThe American Journal of Medicine, 1966
- TREATMENT OF A CASE OF NONTUMOROUS CUSHING'S SYNDROME WITH O,P'DDD.1964
- STUDIES OF PHARMACOLOGY OF O,P'DDD IN MAN1961
- THE TOXICITY AND TOXIC MANIFESTATIONS OF 2,2-BIS-(P-CHLOROPHENYL)-1,1,1-TRICHLOROETHANE (DDT) AS INFLUENCED BY CHEMICAL CHANGES IN THE MOLECULE - A CONTRIBUTION TO THE RELATION BETWEEN CHEMICAL CONSTITUTION AND TOXICOLOGICAL ACTION1946